ストックスクリーナーアプリを入手
23.50
0.13%
0.03
アフターアワーズ：
23.57
0.07
+0.30%
前日終値:
$23.47
開ける：
$23.02
24時間の取引高:
228.24K
Relative Volume:
5.82
時価総額：
$1.01B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$23.01
$24.36
1週間の範囲:
$21.71
$24.36
52週間の値動き範囲:
$21.71
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
BBNX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
23.50 | 1.01B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
129.07 | 224.12B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.25 | 155.19B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.40 | 149.44B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.01 | 114.86B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.35 | 41.68B | 6.60B | 4.16B | 490.10M | 6.93 |
Beta Bionics Inc (BBNX) 最新ニュース
Eventide Asset Management, LLC Acquires Significant Stake in Bet - GuruFocus.com
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO? - Barchart
Beta Bionics: A Sugar Rush For This IPO (NASDAQ:BBNX) - Seeking Alpha
Signals Recap: Ozempic's Latest Approval, EKDA on Reddit, Lilly Stops Relaxin, Beta Bionics IPO, NKF Turns 75, & More... - substack.com
Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon - MSN
Beta Bionics Announces Closing of $234.6 Million Initial - GlobeNewswire
BBNXBeta Bionics, Inc. Latest Stock News & Market Updates - StockTitan
Oil company Infinity Natural Resources debuts IPO amid deregulation push - MSN
4 Firms Guide Pair Of Biotech IPOs Raising $415M Combined - Law360
Beta Bionics raises $204M in IPO - MedTech Dive
Beta Bionics stock opens 29% higher in Nasdaq debut - MSN
Beta Bionics (BBNX) Opens At $22, IPO Priced At $17 By Investing.com - Investing.com Canada
Beta Bionics Goes Public After Raising $204M Upsized Offering - Orange County Business Journal
Bionics Upsized $204M IPO: A Game-Changer for Diabetes Treatment - USA Herald
Beta Bionics raises $204m to kickstart medtech IPO season - Medical Device Network
Beta Bionics Shares Rise in Nasdaq Debut -January 30, 2025 at 12:39 pm EST - Marketscreener.com
Cooley, Latham Steer Beta Bionics' Upsized $204M IPO - Law360
Beta Bionics Rings the Opening Bell - Nasdaq
Insulin delivery device maker Beta Bionics prices further upsized IPO at $17, the high end of the upwardly revised range - Renaissance Capital
Artificial pancreas maker Beta Bionics aims to raise $204M in Nasdaq IPO - MSN
Beta Bionics Set to Revolutionize Diabetes Management with $204 Million IPO! - mivalle.net.ar
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering - GlobeNewswire
Beta Bionics sets terms for upsized $165M IPO - MSN
Beta Bionics sets terms for upsized $165M IPO (BBNX:Pending) - Seeking Alpha
Beta Bionics targets $695 million valuation in upsized US IPO - MSN
BBNX IPO NewsInsulin delivery device maker Beta Bionics increases deal size by 47% ahead of $165 million IPO - Renaissance Capital
IPO Roundup: Smithfield Foods, Beta Bionics and more - MSN
Obesity-Focused Metsera Leads Biotech Firms Eyeing IPOs - Law360
Beta Bionics targets $114M IPO raise to fund insulin pump development - MedTech Dive
Beta Bionics, Inc. (BBNX) Announces January 30th IPO - Defense World
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing - MSN
Beta Bionics Targets $113 Million in IPO, Plans Nasdaq Listing - GuruFocus.com
Beta Bionics sets terms for upsized $113M IPO - MSN
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Beta Bionics Announces Plans for IPO - Orange County Business Journal
Beta Bionics Aims For IPO To Cover Heavy Losses (BBNX) - Seeking Alpha
Beta Bionics, maker of ‘bionic pancreas,’ files for IPO - MedTech Dive
Oilfield Services Firm Flowco Set to Drill Down On $392M IPO - Law360
Beta Bionics Files Registration Statement for Proposed Initial Public Offering - GlobeNewswire
Beta Bionics Raises $60M Series E - Orange County Business Journal
Beta Bionics Announces Closing of a $60 Million Series E Financing - Newswire
Diabetes Dialogue: Diabetes Tech Updates in October 2024 - MD Magazine
Beta Bionics Announces Launch of the iLet Bionic Pancreas With Abbott’s FreeStyle Libre 3 Plus Sensor - Newswire
Abbott expands pump partnerships, launches Lingo CGM - BioWorld Online
Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM - Yahoo Finance
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics - Business Wire
Beta Bionics’ iLet bionic pancreas launches worldwide - Medical Device Network
First AID positions Dexcom for healthy new year - BioWorld Online
Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies - Newswire
Beta Bionics Secures $100M in Series D - MPO-mag
Beta Bionics closes $100M Series D to support bionic pancreas - Drug Delivery Business News
Beta Bionics Inc (BBNX) 財務データ
Beta Bionics Inc (BBNX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Beta Bionics Inc (BBNX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Mensinger Mike | Chief Product Officer |
Jan 31 '25 |
Sale |
17.00 |
13 |
221 |
25,669 |
| Wellington Hadley Harbor Aggre | 10% Owner |
Jan 31 '25 |
Buy |
17.00 |
1,000,000 |
17,000,000 |
3,901,599 |
1.71%
大文字化:
|
ボリューム (24 時間):